The U.S. Food and Drug Administration (FDA) has approved the first generic of Restasis© (cyclosporine ophthalmic emulsion) eye drops to increase tear production in people with chronic dry eye (CDE). Why is a generic product good news? Restasis has been approved for use in the United States for nearly 20 years, but there was no approved generic product of this drug. The approval of a generic version gives millions of people with CDE access to a lower-cost option to treat their symptoms . . .
Published on ChronicDryEye.net on February 22, 2022
